CCL21 and neoplasm: We did not assess CCL21 levels in blood, but patients in the upper quartile for CCL21 gene expression in tumor had longer OS (HR = 0.43, 95% CI 0.23–0.79, p = 0.005), suggesting that this biomarker may be prognostic.